Search - tctmd.com

Displaying 641 - 660 of 849

Sort: Relevancy | Date

News Daily News

Las Directrices Elevan el Ticagrelor a la Categoría de Antiplaquetario de 1ª Línea contra la Angina Inestable

Jason Kahn

July 17, 2012

News Daily News

Meta-analysis: Triple Therapy with Cilostazol Lowers TLR, TVR With No Extra Bleeding

Jason Kahn

July 13, 2012

News Daily News

Meta Análisis: La Triple Terapia con Cilostazol Reduce la RLD y la RVD sin Riesgo Adicional de Hemorragias

Jason Kahn

July 13, 2012

Presentation

Cilostazol Added to Aspirin and Clopidogrel Reduces Revascularization Without Increases in Major Adverse Events in Patients With DES

Presenter: Ryota Sakurai

July 12, 2012

News Daily News

Apixaban Less Costly Than Aspirin for Stroke Prevention in A-Fib at 10 Years

Caitlin E. Cox

July 12, 2012

News Daily News

A los 10 Años el Apixaban resulta Más Barato que la Aspirina para la Prevención de ACV en Pacientes con FA

Caitlin E. Cox

July 12, 2012

Presentation

Cost-Effectiveness of Apixaban vs. Aspirin for Stroke Prevention Among A-fib Pts Unsuitable for Warfarin

Presenter: S. Lee

July 11, 2012

News Daily News

Ticagrelor Provides More Potent Platelet Inhibition Than Prasugrel

July 10, 2012

News Daily News

El Ticagrelor ofrece una Inhibición Plaquetaria Más Potente que el Prasugrel

July 10, 2012

News Industry News

Treatment With Brilinta (Ticagrelor) For 12 Months Is Cost-Effective Versus Generic Clopidogrel, Europe New Data Shows

June 26, 2012

News Daily News

PLATO Subanalysis: Ticagrelor Cost-Effective in ACS Patients

June 26, 2012

News Daily News

Subanálisis del PLATO: El Ticagrelor es Rentable en Pacientes con SCA

June 26, 2012

News Daily News

Signs Point to Relationship Between Clopidogrel Efficacy, Cigarette Smoking

Yael L. Maxwell

June 20, 2012

News Daily News

Señales Apuntan a la Relación que existe entre la Eficacia del Clopidogrel y el Tabaquismo

Yael L. Maxwell

June 20, 2012

News Daily News

Door Still Not Shut on CLOSURE I

Yael L. Maxwell

June 15, 2012

News Daily News

Todavía No se ha Cerrado la Puerta del CLOSURE I

Yael L. Maxwell

June 15, 2012

News Daily News

Platelet Function Recovery Longer After Stopping Prasugrel Than Clopidogrel

June 14, 2012

News Daily News

La Recuperación de la Función Plaquetaria es Más Larga tras la Interrumpción del Prasugrel que del Clopidogrel

June 14, 2012

News Daily News

Antithrombotic Choice During PCI Influences Outcomes in Poor Clopidogrel Responders

Caitlin E. Cox

June 07, 2012

News Daily News

La Opción Antitrombótica durante una PCI Influye en los Resultados de los Malos Respondedores al Clopidogrel

Caitlin E. Cox

June 07, 2012

Advertisement

Las Directrices Elevan el Ticagrelor a la Categoría de Antiplaquetario de 1ª Línea contra la Angina Inestable

Meta-analysis: Triple Therapy with Cilostazol Lowers TLR, TVR With No Extra Bleeding

Meta Análisis: La Triple Terapia con Cilostazol Reduce la RLD y la RVD sin Riesgo Adicional de Hemorragias

Cilostazol Added to Aspirin and Clopidogrel Reduces Revascularization Without Increases in Major Adverse Events in Patients With DES

Apixaban Less Costly Than Aspirin for Stroke Prevention in A-Fib at 10 Years

A los 10 Años el Apixaban resulta Más Barato que la Aspirina para la Prevención de ACV en Pacientes con FA

Cost-Effectiveness of Apixaban vs. Aspirin for Stroke Prevention Among A-fib Pts Unsuitable for Warfarin

Ticagrelor Provides More Potent Platelet Inhibition Than Prasugrel

El Ticagrelor ofrece una Inhibición Plaquetaria Más Potente que el Prasugrel

Treatment With Brilinta (Ticagrelor) For 12 Months Is Cost-Effective Versus Generic Clopidogrel, Europe New Data Shows

PLATO Subanalysis: Ticagrelor Cost-Effective in ACS Patients

Subanálisis del PLATO: El Ticagrelor es Rentable en Pacientes con SCA

Signs Point to Relationship Between Clopidogrel Efficacy, Cigarette Smoking

Señales Apuntan a la Relación que existe entre la Eficacia del Clopidogrel y el Tabaquismo

Door Still Not Shut on CLOSURE I

Todavía No se ha Cerrado la Puerta del CLOSURE I

Platelet Function Recovery Longer After Stopping Prasugrel Than Clopidogrel

La Recuperación de la Función Plaquetaria es Más Larga tras la Interrumpción del Prasugrel que del Clopidogrel

Antithrombotic Choice During PCI Influences Outcomes in Poor Clopidogrel Responders

La Opción Antitrombótica durante una PCI Influye en los Resultados de los Malos Respondedores al Clopidogrel

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content